Stereotaxis, Inc. is developing solutions in computer integrated interventional medicine. The Company's core technology is a proprietary interventional workstation and toolkit of related disposables (collectively referred to as the "Stereotaxis System") designed to be capable of remotely directing and digitally controlling catheter based therapeutic and diagnostic devices along complex trajectories within the body, providing potential important solutions to major interventional challenges. Stereotaxis received 510(k) clearance from the FDA for its Telstar General Navigation system and bi-plane flat plate digital imaging platform as well as its EP mapping catheter in May 2002.
